These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35428012)

  • 1. Discovery of 4-((E)-3,5-dimethoxy-2-((E)-2-nitrovinyl)styryl)aniline derivatives as potent and orally active NLRP3 inflammasome inhibitors for colitis.
    Zhang XX; Diao LZ; Chen LZ; Ma D; Wang YM; Jiang H; Ruan BF; Liu XH
    Eur J Med Chem; 2022 Jun; 236():114357. PubMed ID: 35428012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Novel Pterostilbene-Based Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors with Inflammatory Activity for Colitis.
    Chen LZ; Zhang XX; Liu MM; Wu J; Ma D; Diao LZ; Li Q; Huang YS; Zhang R; Ruan BF; Liu XH
    J Med Chem; 2021 Sep; 64(18):13633-13657. PubMed ID: 34506712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Novel Tetrahydroquinoline Inhibitors of NLRP3 Inflammasome for Potential Treatment of DSS-Induced Mouse Colitis.
    Dai Z; Chen XY; An LY; Li CC; Zhao N; Yang F; You ST; Hou CZ; Li K; Jiang C; You QD; Di B; Xu LL
    J Med Chem; 2021 Jan; 64(1):871-889. PubMed ID: 33332136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Isoalantolactone-Based Derivatives as Potent NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization.
    Zhao M; Ye N; Liu L; Zhang RJ; Li N; Peng J; Cai XY; Jiang XQ; Su KY; Zhang XL; Rao QR; Liu KJ; Deng DX; Peng AH; Tang MH; Chen LJ; Wu WS; Ye HY
    J Med Chem; 2024 May; 67(9):7516-7538. PubMed ID: 38686671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of chalcone analogues as novel NLRP3 inflammasome inhibitors with potent anti-inflammation activities.
    Zhang C; Yue H; Sun P; Hua L; Liang S; Ou Y; Wu D; Wu X; Chen H; Hao Y; Hu W; Yang Z
    Eur J Med Chem; 2021 Jul; 219():113417. PubMed ID: 33845232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAFF Blockade Attenuates DSS-Induced Chronic Colitis
    Zhang Y; Tao M; Chen C; Zhao X; Feng Q; Chen G; Fu Y
    Front Immunol; 2022; 13():783254. PubMed ID: 35320937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
    Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
    Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAP-1 ameliorates DSS-induced colitis with involvement of NLRP3 inflammasome pathway.
    Mei Y; Fang C; Ding S; Liu X; Hu J; Xu J; Mei Q
    Int Immunopharmacol; 2019 Oct; 75():105776. PubMed ID: 31351364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
    Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
    Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel oridonin analogs as specifically targeted NLRP3 inflammasome inhibitors for the treatment of dextran sulfate sodium-induced colitis.
    Pang L; Liu H; Quan H; Sui H; Jia Y
    Eur J Med Chem; 2023 Jan; 245(Pt 2):114919. PubMed ID: 36399877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huaier aqueous extract protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NLRP3 inflammasome activation.
    Wang L; Yu Z; Wei C; Zhang L; Song H; Chen B; Yang Q
    Oncotarget; 2017 May; 8(20):32937-32945. PubMed ID: 28380426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production.
    Gong Z; Zhao S; Zhou J; Yan J; Wang L; Du X; Li H; Chen Y; Cai W; Wu J
    Mol Immunol; 2018 Dec; 104():11-19. PubMed ID: 30396035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a Novel Oral Proteasome Inhibitor to Block NLRP3 Inflammasome Activation with Anti-inflammation Activity.
    Wu X; Sun P; Chen X; Hua L; Cai H; Liu Z; Zhang C; Liang S; Chen Y; Wu D; Ou Y; Hu W; Yang Z
    J Med Chem; 2022 Sep; 65(18):11985-12001. PubMed ID: 36063115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel biphenyl-sulfonamide analogues as NLRP3 inflammasome inhibitors.
    Huang C; Liu J; Chen Y; Sun S; Kang T; Jiang Y; Li X
    Bioorg Chem; 2024 May; 146():107263. PubMed ID: 38492493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation.
    Du X; Chen W; Wang Y; Chen C; Guo L; Ju R; Li J; Zhang D; Zhu L; Ye C
    Int Immunopharmacol; 2017 Apr; 45():16-25. PubMed ID: 28152446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jmjd3 regulates inflammasome activation and aggravates DSS-induced colitis in mice.
    Huang M; Wang Q; Long F; Di Y; Wang J; Zhun Zhu Y; Liu X
    FASEB J; 2020 Mar; 34(3):4107-4119. PubMed ID: 31971317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages.
    Simovic Markovic B; Nikolic A; Gazdic M; Bojic S; Vucicevic L; Kosic M; Mitrovic S; Milosavljevic M; Besra G; Trajkovic V; Arsenijevic N; Lukic ML; Volarevic V
    J Crohns Colitis; 2016 May; 10(5):593-606. PubMed ID: 26786981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of dronedarone and its analogues as NLRP3 inflammasome inhibitors with potent anti-inflammation activity.
    Chen H; Chen X; Sun P; Wu D; Yue H; Pan J; Li X; Zhang C; Wu X; Hua L; Hu W; Yang Z
    Bioorg Med Chem Lett; 2021 Aug; 46():128160. PubMed ID: 34062252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbyl palmitate ameliorates inflammatory diseases by inhibition of NLRP3 inflammasome.
    Zhang L; Li G; Lin B; He H; Zhou R; Jiang W
    Int Immunopharmacol; 2024 Apr; 131():111915. PubMed ID: 38522141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen sulfide protects against DSS-induced colitis by inhibiting NLRP3 inflammasome.
    Qin M; Long F; Wu W; Yang D; Huang M; Xiao C; Chen X; Liu X; Zhu YZ
    Free Radic Biol Med; 2019 Jun; 137():99-109. PubMed ID: 31026586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.